Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomised Controlled Trial Comparing Alternative Regimens for Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer

NCT04116047 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT04116047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04116047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomised Controlled Trial Comparing Alternative Regimens for Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer
Lead sponsor
University of Birmingham
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 31, 2015
Completion date
December 31, 2030
Enrollment
785 (estimated)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

oropharyngeal cancer